Osaka City University, Osaka, Japan.
Hepatol Res. 2009 Jan;39(1):47-52. doi: 10.1111/j.1872-034X.2008.00410.x. Epub 2008 Aug 28.
The differing efficacies of radiofrequency ablation and microwave coagulation for hepatocellular carcinoma (HCC) are unknown. Therefore, we performed a multi-center study to assess the factors contributing to survival and local recurrences of HCC among patients with solitary tumors who underwent endoscopic thermal ablation as their primary treatment.
From six institutions, 391 patients with solitary HCC who were first treated by endoscopic thermal ablation were enrolled in this study and assessed retrospectively. We investigated age, gender, location of tumor, longest diameter of tumor, method of anesthesia, type of endoscope, method of thermal ablation, Child-Pugh classification, the Japan Integrated Staging score and the Cancer of the Liver Italian Program score. Statistical analyses were performed using univariate analysis with log-rank test and multivariate analysis with the Cox proportional hazards model.
On univariate analysis, advanced Child-Pugh score, advanced Italian Program score and local recurrences were significant predictors of poor survival. Young age (</=70), large tumor (>30 mm) and the use of the thoracoscopic approach were significant predictors for the development of local recurrence. On multivariate analysis, local anesthesia and advanced Child-Pugh score were independent predictors of poor survival. Young age, large tumor, local anesthesia and the use of the thoracoscopic approach were independent predictors for the development of local recurrence. The method of thermal ablation did not influence survival or local recurrence.
Differences in the effect on survival and local recurrence between microwave and radiofrequency were not observed in this retrospective, multi-center study of endoscopic thermal ablation for HCC.
射频消融和微波凝固治疗肝细胞癌(HCC)的疗效存在差异,但目前尚不清楚。因此,我们进行了一项多中心研究,以评估接受内镜热消融作为主要治疗方法的单发肿瘤 HCC 患者的生存和局部复发的相关因素。
从 6 家机构共招募了 391 例因单发 HCC 首次接受内镜热消融治疗的患者,并进行回顾性评估。我们调查了年龄、性别、肿瘤位置、肿瘤最长径、麻醉方法、内镜类型、热消融方法、Child-Pugh 分级、日本综合分期评分和意大利肝癌计划评分。使用对数秩检验进行单因素分析和 Cox 比例风险模型进行多因素分析。
单因素分析显示,Child-Pugh 分级较高、意大利肝癌计划评分较高和局部复发是生存不良的显著预测因素。年龄较小(<=70 岁)、肿瘤较大(>30mm)和采用胸腔镜入路是局部复发的显著预测因素。多因素分析显示,局部麻醉和 Child-Pugh 分级较高是生存不良的独立预测因素。年龄较小、肿瘤较大、局部麻醉和胸腔镜入路是局部复发的独立预测因素。热消融方法对生存或局部复发没有影响。
在这项 HCC 内镜热消融的回顾性多中心研究中,未观察到射频和微波在生存和局部复发方面的疗效差异。